Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1998-3-5
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0895-0172
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
9
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
626-7
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:9447510-Adult,
pubmed-meshheading:9447510-Antipsychotic Agents,
pubmed-meshheading:9447510-Clozapine,
pubmed-meshheading:9447510-Humans,
pubmed-meshheading:9447510-Male,
pubmed-meshheading:9447510-Schizophrenia,
pubmed-meshheading:9447510-Schizophrenic Psychology,
pubmed-meshheading:9447510-Substance-Related Disorders
|
pubmed:year |
1997
|
pubmed:articleTitle |
Substance abuse in clozapine-treated schizophrenic patients.
|
pubmed:publicationType |
Letter,
Case Reports
|